FCMI

Foresite Capital Management II Portfolio holdings

AUM $29.2M
1-Year Est. Return 44.84%
This Quarter Est. Return
1 Year Est. Return
+44.84%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$201M
AUM Growth
-$87.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$2.7M
2
+$2.59M
3
+$2.57M
4
RGLS
Regulus Therapeutics
RGLS
+$2M
5
XLRN
Acceleron Pharma
XLRN
+$967K

Top Sells

1
+$4.28M
2
+$3.08M
3
+$1.17M
4
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$660K
5
LRMR icon
Larimar Therapeutics
LRMR
+$442K

Sector Composition

1 Healthcare 66.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$55.4M 27.13%
4,087,900
2
$20.1M 9.84%
2,814,883
3
$16.9M 8.29%
264,583
-66,816
4
$14.4M 7.07%
1,191,995
+32,200
5
$14.3M 7.01%
1,761,567
6
$14.1M 6.92%
16,991
+2,402
7
$13M 6.36%
530,416
+110,419
8
$11.5M 5.65%
949,372
+211,011
9
$10M 4.91%
659,486
+170,000
10
$9.5M 4.65%
118,523
-5,511
11
$4.59M 2.25%
174,089
+36,631
12
$3.64M 1.78%
468,297
-10,000
13
$3.64M 1.78%
646,208
+23,703
14
$2.93M 1.43%
887,801
+13,800
15
$2.4M 1.18%
743,395
-204,420
16
$1.69M 0.83%
156,741
17
$1.69M 0.83%
119,781
+64,002
18
$1.36M 0.67%
33,718
19
– –
-8,125
20
– –
-4,804
21
– –
0